Last reviewed · How we verify
NCT07075679: AI-BCSQ
Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ)
NA trial testing Group with AI iCAD version 3 in Breast Cancer Screening in 8,000 participants. Currently enrolling.
5 October 2028
Quick facts
| Lead sponsor | University Hospital Olomouc |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 8,000 |
| Start date | 6 October 2025 |
| Primary completion | 5 October 2028 |
| Estimated completion | 5 October 2028 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Group with AI iCAD version 3
- Group without AI
Conditions studied
- Breast Cancer Screening — all drugs for Breast Cancer Screening →
- Artificial Intelligence (AI) — all drugs for Artificial Intelligence (AI) →
- Breast Cancer Screening and Diagnosis — all drugs for Breast Cancer Screening and Diagnosis →
Sponsor
University Hospital Olomouc
Who can join
Adults 45 to 69, female only, with Breast Cancer Screening or Artificial Intelligence (AI). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized prospective study comparing the evaluation of mammography images in a breast cancer screening programme by a single radiologist with AI support versus standard double reading by two radiologists without AI support.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07075679
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Screening
Currently open trials in the same condition.
- NCT07067788 — B.Brilliant Revelation Comparision Study · recruiting
- NCT06934239 — A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detec · Phase 4 · recruiting
- NCT06876610 — Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer · recruiting
- NCT07411443 — AI-Enhanced Imaging in Population Breast Cancer Screening · NA · recruiting
- NCT06059300 — Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening Program · NA · active not recruiting
Other University Hospital Olomouc trials
Trials by the same sponsor.
- NCT06981026 — The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectom · NA · not yet recruiting
- NCT07356076 — The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases · recruiting
- NCT07360886 — Early Detection of Selected Neuropathologies in Motor Vehicle Drivers · recruiting
- NCT06050057 — Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy · recruiting
- NCT06964425 — Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07075679 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Olomouc
- Last refreshed: 2 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07075679.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing